Canna~Fangled Abstracts Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey Epilepsy Res. 2023 Dec 14:200:107280. doi: 10.1016/j.eplepsyres.2023.107280. Online ahead of print. Anne T Berg 1, Tracy Dixon-Salazar 2, Mary…Freedom WaresDecember 14, 2023
Canna~Fangled Abstracts Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: post hoc analysis of patients receiving cannabidiol in two randomized controlled trials Epilepsia. 2023 Apr 13. doi: 10.1111/epi.17618. Online ahead of print. Stéphane Auvin 1 2 3, Charlotte Nortvedt 4, Douglas S Fuller 5, Farhad…Freedom WaresApril 12, 2023
Canna~Fangled Abstracts Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis Review Dev Med Child Neurol. 2021 Sep 30. doi: 10.1111/dmcn.15072. Online ahead of print. Lanlan…Freedom WaresSeptember 30, 2021
Canna~Fangled Abstracts Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial Epilepsia. 2021 Jul 20. doi: 10.1111/epi.17000. Online ahead of print. Anup D Patel 1, Maria Mazurkiewicz-Bełdzińska 2, Richard F…Freedom WaresJuly 22, 2021
Canna~Fangled Abstracts Time to onset of cannabidiol (CBD) treatment effect in Lennox-Gastaut syndrome: Analysis from two randomized controlled trials Treatment effect (efficacy and AEs) of CBD may occur within 1 week of starting treatment.…Freedom WaresApril 2, 2021
For Your Consideration... Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study. Epilepsia. 2019 Feb 11. doi: 10.1111/epi.14670. Thiele E1, Marsh E2, Mazurkiewicz-Beldzinska M3, Halford JJ4, Gunning…Freedom WaresFebruary 11, 2019
Canna~Fangled Abstracts Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. N Engl J Med. 2018 May 17;378(20):1888-1897. doi: 10.1056/NEJMoa1714631. Devinsky O1, Patel AD1, Cross JH1,…Freedom WaresMay 17, 2018
Canna~Fangled Abstracts Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018 Jan 25. pii: S0140-6736(18)30136-3. doi: 10.1016/S0140-6736(18)30136-3. Thiele EA1, Marsh ED2, French JA3, Mazurkiewicz-Beldzinska…Freedom WaresJanuary 25, 2018